Woody Joseph Fralin's Form 4 filing
AVITA Medical, Inc. (RCEL) · filed Jun 3, 2026
- Accession no.
- 0001709989-26-000006
- Filed
- Jun 3, 2026
- Trade date
- Jun 1-2, 2026
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not checked
This filing lists 4 non-derivative transactions. Open-market purchases total $85.0K. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Woody Joseph FralinCIK 0001709989 | Director |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jun 1, 2026 | Common Stock | PPurchaseAcquired | +5,000 | $4.34 | +$21,700 | 5,000 | Direct | |
| Jun 1, 2026 | Common Stock | PPurchaseAcquired | +5,000 | $4.26 | +$21,300 | 10,000 | Direct | |
| Jun 2, 2026 | Common Stock | PPurchaseAcquired | +5,000 | $4.18 | +$20,900 | 15,000 | Direct | |
| Jun 2, 2026 | Common Stock | PPurchaseAcquired | +5,000 | $4.21 | +$21,050 | 20,000 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
No transaction price on this filing refers to a footnote.